This correction is made in compliance with Section 39n(3) of the Act and becomes effective on the day it is published on the official notice board. The List’s correction lays down the full list of medicinal products (MPs) and foods for special medicinal purposes (FSMPs) reimbursed from the public health insurance system subject to the Institute’s decision, including their maximum or announced ex-factory prices, the amount and the terms of reimbursement, incl. their highest possible reimbursement for the end consumer, along with the amount of the extra payment in the eligible limit. In addition, the List contains the basic reimbursements of reference groups and explains the reasoning behind the basic reimbursements, along with a full list of the medicinal products and foods for special medicinal purposes included in the reference groups.
In the published correction the Institute corrected reimbursement price for NEUPOGEN 30 MU/0,5ML INJ SOL 5X0,5ML, code SÚKL 0078914 and NEUPOGEN 48 MU/0,5ML INJ SOL 5X0,5ML, code SÚKL 0078906. Furthermore the ODTD (usual daily therapeutic dose) was corrected for TEVAGRASTIM, codes SÚKL 0500683, 0149993, 0500687 and 0149996 without any influence on the reimbursement price. Also reimbursement for ODTD was corrected for HUMALOG, codes SÚKL 0029691, 0029693, 0029689 together with correction of the reimbursement price.
List of prices of medicinal products and fedical purposes
- SCAU150113.xls, soubor typu xls, (5,27 MB) - plný soubor s aktuálními úhradami
List of prices of medicinal products and foods for special medical purposes used in institutional care only